Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Obesity | Research article

Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years

Authors: Pei-yuan Su, Yu-Chun Hsu, Yu-fang Cheng, Chew-Teng Kor, Wei-Wen Su

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Age, obesity, and metabolic syndrome are known risk factors for gallstones; however, the combined impact of these different risk factors on gallstone formation has not yet been examined.

Methods

This retrospective, cross-sectional study involved 3190 participants, including 207 participants (6.5%) with gallstones and 986 (30.9%) with metabolic syndrome. Participants were divided into four phenotypes according to metabolic syndrome and obesity status: 1378 participants were metabolically healthy and non-obese (MHNO); 826 were metabolically healthy but obese (MHO); 185 were metabolically abnormal but not obese (MANO); and 801 participants were metabolically abnormal and obese (MAO).

Results

The MAO and MANO phenotypes had more gallstones than the MHO and MHNO phenotypes, regardless of age (< 50 or ≥ 50 years old). Multivariate analyses showed that phenotype was an independent risk factor for gallstones in participants < 50 years old (odds ratio (OR) = 1.73, 95% confidence interval (CI) = 1.32–2.28). Younger participants also had a higher risk of gallstones in the MAO (OR = 5.41, 95% CI = 2.31–12.66), MANO (OR = 3.18, 95% CI = 0.86–11.75), and MHO (OR = 2.17, 95% CI = 0.90–5.22) phenotypes than the MHNO phenotype.

Conclusions

Our retrospective results demonstrate an increased association of gallstones in younger people (< 50 years old) with metabolic syndrome and obesity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34:81–9.CrossRef Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34:81–9.CrossRef
2.
go back to reference Lammert F, Acalovschi M, Ercolani G, et al. EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65:146–81.CrossRef Lammert F, Acalovschi M, Ercolani G, et al. EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65:146–81.CrossRef
3.
go back to reference Lin I-C, Yang Y-W, Wu M-F, et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Fam Pract. 2014;15:138.CrossRef Lin I-C, Yang Y-W, Wu M-F, et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Fam Pract. 2014;15:138.CrossRef
4.
go back to reference Li X, Guo X, Ji H, Yu G, Gao P. Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int. 2017;2017:9749802. Li X, Guo X, Ji H, Yu G, Gao P. Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int. 2017;2017:9749802.
5.
go back to reference Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Prim. 2016;2:16024.CrossRef Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Prim. 2016;2:16024.CrossRef
6.
go back to reference Shabanzadeh DM, Skaaby T, Sørensen LT, Eugen-Olsen J, Jørgensen T. Metabolic biomarkers and gallstone disease–a population-based study. Scand J Gastroenterol. 2017;52:1270–7.CrossRef Shabanzadeh DM, Skaaby T, Sørensen LT, Eugen-Olsen J, Jørgensen T. Metabolic biomarkers and gallstone disease–a population-based study. Scand J Gastroenterol. 2017;52:1270–7.CrossRef
7.
go back to reference Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg. 2017;17:7–13.CrossRef Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg. 2017;17:7–13.CrossRef
8.
go back to reference Zhu Q, Sun X, Ji X, et al. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. Sci Rep. 2016;6:1–9.CrossRef Zhu Q, Sun X, Ji X, et al. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. Sci Rep. 2016;6:1–9.CrossRef
9.
go back to reference Tsai CH, Wu JS, Chang YF, Lu FH, Yang YC, Chang CJ. The number of metabolic abnormalities associated with the risk of gallstones in a non-diabetic population. PLoS One. 2014;9:1–6. Tsai CH, Wu JS, Chang YF, Lu FH, Yang YC, Chang CJ. The number of metabolic abnormalities associated with the risk of gallstones in a non-diabetic population. PLoS One. 2014;9:1–6.
10.
go back to reference Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19.CrossRef Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19.CrossRef
11.
go back to reference Bonfrate L, DQH W, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28:623–35.CrossRef Bonfrate L, DQH W, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28:623–35.CrossRef
12.
go back to reference Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569–75.CrossRef Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569–75.CrossRef
13.
go back to reference Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Asp Med. 2013;34:59–70.CrossRef Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Asp Med. 2013;34:59–70.CrossRef
14.
go back to reference Kim TJ, Kim ER, Hong SN, et al. Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia. Sci Rep. 2017;7:9011.CrossRef Kim TJ, Kim ER, Hong SN, et al. Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia. Sci Rep. 2017;7:9011.CrossRef
15.
go back to reference Luo D, Liu F, Li X, et al. Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine. 2015;49:130–8.CrossRef Luo D, Liu F, Li X, et al. Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine. 2015;49:130–8.CrossRef
16.
go back to reference Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10:578–83.CrossRef Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10:578–83.CrossRef
17.
go back to reference KGMM A, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international. Circulation. 2009;120:1640–5.CrossRef KGMM A, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international. Circulation. 2009;120:1640–5.CrossRef
18.
go back to reference WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: Health Communications Australia; 2000. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: Health Communications Australia; 2000.
19.
go back to reference Venneman NG, van Erpecum KJ. Pathogenesis of gallstones. Gastroenterol Clin N Am. 2010;39:171–83.CrossRef Venneman NG, van Erpecum KJ. Pathogenesis of gallstones. Gastroenterol Clin N Am. 2010;39:171–83.CrossRef
20.
go back to reference Chen J-Y, Hsu C-T, Liu J-H, Tung T-H. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83.CrossRef Chen J-Y, Hsu C-T, Liu J-H, Tung T-H. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83.CrossRef
21.
go back to reference Denis GV, Obin MS. “Metabolically healthy obesity”: origins and implications. Mol Asp Med. 2013;34:59–70.CrossRef Denis GV, Obin MS. “Metabolically healthy obesity”: origins and implications. Mol Asp Med. 2013;34:59–70.CrossRef
22.
go back to reference Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–62.CrossRef Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–62.CrossRef
23.
go back to reference Denis GV, Hamilton JA. Healthy obese persons: how can they be identified and do metabolic profiles stratify risk? Curr Opin Endocrinol Diabetes Obes. 2013;20:369–76.CrossRef Denis GV, Hamilton JA. Healthy obese persons: how can they be identified and do metabolic profiles stratify risk? Curr Opin Endocrinol Diabetes Obes. 2013;20:369–76.CrossRef
24.
go back to reference Blüher M. Mechanisms in endocrinology: are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014;171:R209–19.CrossRef Blüher M. Mechanisms in endocrinology: are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014;171:R209–19.CrossRef
25.
go back to reference Ryoo JH, Park SK, Ye S, et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine. 2015;50:650–8.CrossRef Ryoo JH, Park SK, Ye S, et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine. 2015;50:650–8.CrossRef
26.
go back to reference Shen HC, Hu YC, Chen YF, Tung TH. Prevalence and associated metabolic factors of gallstone disease in the elderly agricultural and fishing population of taiwan. Gastroenterol Res Pract. 2014;2014:876918.CrossRef Shen HC, Hu YC, Chen YF, Tung TH. Prevalence and associated metabolic factors of gallstone disease in the elderly agricultural and fishing population of taiwan. Gastroenterol Res Pract. 2014;2014:876918.CrossRef
27.
go back to reference Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin N Am. 2010;39:157–69.CrossRef Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin N Am. 2010;39:157–69.CrossRef
28.
go back to reference Lirussi F, Nassuato G, Passera D, et al. Gallstone disease in an elderly population: the Silea study. Eur J Gastroenterol Hepatol. 1999;11:485–91.CrossRef Lirussi F, Nassuato G, Passera D, et al. Gallstone disease in an elderly population: the Silea study. Eur J Gastroenterol Hepatol. 1999;11:485–91.CrossRef
29.
go back to reference Agrusa A, Romano G, Frazzetta G, et al. Role and outcomes of laparoscopic cholecystectomy in the elderly. Int J Surg. 2014;12:S37–9.CrossRef Agrusa A, Romano G, Frazzetta G, et al. Role and outcomes of laparoscopic cholecystectomy in the elderly. Int J Surg. 2014;12:S37–9.CrossRef
30.
go back to reference Magnuson TH, Ratner LE, Zenilman ME, Bender JS. Laparoscopic cholecystectomy: applicability in the geriatric population. Am Surg. 1997;63:91–6.PubMed Magnuson TH, Ratner LE, Zenilman ME, Bender JS. Laparoscopic cholecystectomy: applicability in the geriatric population. Am Surg. 1997;63:91–6.PubMed
31.
go back to reference Li X, Gao P. Hepatitis C virus infection increases risk of gallstone disease in elderly Chinese patients with chronic liver disease. Sci Rep. 2018;8:14–9.CrossRef Li X, Gao P. Hepatitis C virus infection increases risk of gallstone disease in elderly Chinese patients with chronic liver disease. Sci Rep. 2018;8:14–9.CrossRef
32.
go back to reference Wong RJ, Gish RG. Metabolic manifestations and complications associated with chronic hepatitis C virus infection. Gastroenterol Hepatol (NY). 2016;12:293–9. Wong RJ, Gish RG. Metabolic manifestations and complications associated with chronic hepatitis C virus infection. Gastroenterol Hepatol (NY). 2016;12:293–9.
33.
go back to reference Stepanova M, Lam B, Younossi Y, Srishord MK, Younossi ZM. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J Viral Hepat. 2012;19:341–5.CrossRef Stepanova M, Lam B, Younossi Y, Srishord MK, Younossi ZM. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J Viral Hepat. 2012;19:341–5.CrossRef
34.
go back to reference Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat. 2009;16:860–6.CrossRef Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat. 2009;16:860–6.CrossRef
35.
go back to reference Negro F. HCV infection and metabolic syndrome: which is the chicken and which is the egg? Gastroenterology. 2012;142:1288–92.CrossRef Negro F. HCV infection and metabolic syndrome: which is the chicken and which is the egg? Gastroenterology. 2012;142:1288–92.CrossRef
Metadata
Title
Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years
Authors
Pei-yuan Su
Yu-Chun Hsu
Yu-fang Cheng
Chew-Teng Kor
Wei-Wen Su
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1032-y

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.